Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that BMP4 and Smad4 suppress TNF-α-driven Samd9l activation to prevent inflammatory cell death in osteoblasts, highlighting a therapeutic mechanism for bone...
Inflammation-induced osteoblast death disrupts bone homeostasis. However, how pro-survival bone morphogenetic protein (BMP) signaling intersects with the tumor necrosis factor (TNF)–NF-κB pathways remains unclear. Here we show that BMP4 protection of mouse osteoblasts from TNF-α–triggered inflammatory cell death requires Smad4 and NF-κB p65. ChIP-seq and ATAC-seq under TNF-α and BMP4 co-stimulation reveal broad overlap of Smad4 and p65 binding. Peak-shape–based quality scoring ranks two Samd9l -proximal accessible elements as the top candidates among ~20,000 peaks. These elements contact the Samd9l promoter, act as TNF-α–responsive enhancers and are required for Samd9l induction. One element mediates BMP4–Smad4-dependent attenuation of TNF-α–driven output. Samd9l depletion reduces TNF-α–induced cell-death-associated responses, and enhances ectopic bone formation in vivo. The corresponding mouse elements map to a regulatory region near the human SAMD9L locus. Together, these data delineate an enhancer-resolution BMP4–Smad4 brake on inflammatory NF-κB output that limits Samd9l -dependent osteoblast death, providing a mechanistic framework for supporting osteoblast survival during inflammation.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: